Nerve Burial for Preventing Neuralgia After Total Knee Arthroplasty
Primary Purpose
Neuralgia, Osteoarthritis of the Knee
Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Total knee arthroplasty with Saphenous nerve burial
Standard total knee arthroplasty
Sponsored by
About this trial
This is an interventional prevention trial for Neuralgia focused on measuring Total Knee Arthroplasty
Eligibility Criteria
Inclusion Criteria:
- Must have symptomatic knee osteoarthritis under consideration for total knee arthroplasty
- Must be willing to undergo randomization
Exclusion Criteria:
- Age <18 or >80 years
- Known pre-operative diagnosis of neuralgia, complex regional pain syndrome, or neuropathy, about the operative lower extremity
- Known pre-operative psychiatric disorder requiring medication
- Previous surgery about the operative knee
- BMI > 40 kg/m2 (potential increased risk of soft tissue dissection through adipose)
- Ongoing pre-operative narcotic use in excess of 20 mg morphine equivalents per day for at least one month or pre-operative intravenous drug use (increased potential for complex regional pain syndrome and neuralgia, increased likelihood to require greater post-operative analgesia)
- Ongoing pre-operative use of neuropathic pain medications (gabapentin, pregabalin, amitriptyline, etc.)
- Medical comorbidities (American Society of Anesthesiologists grade > 3 or deemed unfit by consulting internist) precluding elective TKA
- Significant language barrier (reading comprehension less than 8th grade reading level) or mental condition precluding accurate self-assessment of knee pain or function.
- Severe medication allergies to permissible post-operative analgesics (acetaminophen, tramadol, oxycodone, oxycontin, dilaudid)
Sites / Locations
- Medstar Union Memorial Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Control
Intervention
Arm Description
Standard total knee arthroplasty performed through medial parapatellar approach
Total knee arthroplasty performed through medial parapatellar approach with identification, ligation, and burial of saphenous nerve branches
Outcomes
Primary Outcome Measures
Incidence of neuralgia
Measured by DN4 validated scoring tool
Secondary Outcome Measures
Oxford Knee Score
Kneeling weight
Ability to kneel with body weight on affected knee
Full Information
NCT ID
NCT02885467
First Posted
August 26, 2016
Last Updated
May 17, 2018
Sponsor
Medstar Health Research Institute
1. Study Identification
Unique Protocol Identification Number
NCT02885467
Brief Title
Nerve Burial for Preventing Neuralgia After Total Knee Arthroplasty
Official Title
Saphenous Nerve Brach Burial for Preventing Neuralgia After Total Knee Arthroplasty: A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
May 2018
Overall Recruitment Status
Terminated
Why Stopped
Terminated by IRB
Study Start Date
August 2013 (undefined)
Primary Completion Date
May 2018 (Actual)
Study Completion Date
May 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medstar Health Research Institute
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a randomized study investigating whether identification, ligation, and burial of superficial branches of the saphenous nerve crossing the surgical field during total knee arthroplasty reduces the rate of post-operative anterior knee pain and neuralgia compared to standard total knee arthroplasty.
Detailed Description
Anterior knee pain is common after total knee arthroplasty. The incision necessarily travels through the path of a cutaneous nerve - branches of the saphenous nerve. Historically, no effort has been made to separate these branches and bury them away from the surgical scar. It has been noted that some patients develop a painful neuroma, that once resected results in a pain free knee. Investigators are trying to study if identification, ligation, and proper burial of the nerve can prevent the development of neuralgia compared to the typical surgical approach which ignores the nerve branches completely.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neuralgia, Osteoarthritis of the Knee
Keywords
Total Knee Arthroplasty
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
58 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Standard total knee arthroplasty performed through medial parapatellar approach
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Total knee arthroplasty performed through medial parapatellar approach with identification, ligation, and burial of saphenous nerve branches
Intervention Type
Procedure
Intervention Name(s)
Total knee arthroplasty with Saphenous nerve burial
Intervention Type
Procedure
Intervention Name(s)
Standard total knee arthroplasty
Primary Outcome Measure Information:
Title
Incidence of neuralgia
Description
Measured by DN4 validated scoring tool
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Oxford Knee Score
Time Frame
2 years
Title
Kneeling weight
Description
Ability to kneel with body weight on affected knee
Time Frame
2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Must have symptomatic knee osteoarthritis under consideration for total knee arthroplasty
Must be willing to undergo randomization
Exclusion Criteria:
Age <18 or >80 years
Known pre-operative diagnosis of neuralgia, complex regional pain syndrome, or neuropathy, about the operative lower extremity
Known pre-operative psychiatric disorder requiring medication
Previous surgery about the operative knee
BMI > 40 kg/m2 (potential increased risk of soft tissue dissection through adipose)
Ongoing pre-operative narcotic use in excess of 20 mg morphine equivalents per day for at least one month or pre-operative intravenous drug use (increased potential for complex regional pain syndrome and neuralgia, increased likelihood to require greater post-operative analgesia)
Ongoing pre-operative use of neuropathic pain medications (gabapentin, pregabalin, amitriptyline, etc.)
Medical comorbidities (American Society of Anesthesiologists grade > 3 or deemed unfit by consulting internist) precluding elective TKA
Significant language barrier (reading comprehension less than 8th grade reading level) or mental condition precluding accurate self-assessment of knee pain or function.
Severe medication allergies to permissible post-operative analgesics (acetaminophen, tramadol, oxycodone, oxycontin, dilaudid)
Facility Information:
Facility Name
Medstar Union Memorial Hospital
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21218
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Nerve Burial for Preventing Neuralgia After Total Knee Arthroplasty
We'll reach out to this number within 24 hrs